Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Synthesis|August 11, 2020
Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic PainGuanguan Li, Lalit K Golani, Rajwana Jahan, et al.
ACS Omega|May 23, 2022
Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in RatsCarly Baehr, Christine Robinson, Andrew Kassick, et al.
Journal of Medicinal Chemistry|May 29, 2026
Prophylactic Active Immunization Protects against Xylazine-Induced Pharmacological Effects in RatsCaroline M Kim, Robert W Seaman, Courtney Marecki, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 CoreAllison Zarkin, Rajwana Jahan, Rajendra Uprety, et al.
ACS Pharmacology & Translational Science|May 20, 2022
Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in RatsBethany Crouse, Mariah M Wu, Valeria Gradinati, et al.
American Journal of Respiratory Cell and Molecular Biology|September 26, 2015
Targeting the γ-Aminobutyric Acid A Receptor α4 Subunit in Airway Smooth Muscle to Alleviate BronchoconstrictionGene T Yocum, George Gallos, Yi Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2019
The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain InjuryJeffrey M Witkin, Guanguan Li, Lalit K Golani, et al.
Alcoholism, Clinical and Experimental Research|March 13, 2019
GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric ModulatorsLais F Berro, Daniela Rüedi-Bettschen, Jemma E Cook, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine PoisoningJason Kang, Ruowen Xu, Shea Lee, et al.
Structure (London, England : 1993)|December 13, 2022
Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of bindingJustas V Rodarte, Carly Baehr, Dustin Hicks, et al.
Pageof 2